+39 06 5782665
contact@donawa.com
Europe - UK - USA
A Leading CRO and Regulatory Consultancy for US and EU Medical Devices and IVDs
Clinical and regulatory services aligned with client objectives and regulatory expectations

COMPANY NEWS

Clinical Project Management: Webinar on 22nd October 2026
Running a medical device or IVD clinical study involves dozens of activities across three phases: preparation, enrolment, and close-out. A team carries out the work, but someone has to know what must happen, when, and who is responsible. That is clinical project management, and it is the part of a study less experienced Study Sponsors...
October 12, 2026
Donawa Lifescience launches Donawa InTeam flexible clinical staffing service

Donawa Lifescience has launched the Donawa InTeam flexible clinical staffing service to provide medical device and IVD companies fast access to qualified clinical professionals — Clinical Project Managers, Clinical Research Associates and Clinical Study Assistants — who join the client’s team on a fixed assignment, with none of the delays typically associated with recruitment. Through Donawa…

September 14, 2026
Donawa Lifescience helps Tournicare achieve US marketing clearance for ARMA OTC BPM

The Australian start-up company Tournicare Pty Ltd has achieved US marketing clearance from the Food and Drug Administration (FDA) for its ARMA over-the-counter Blood Pressure Monitor (BPM) via the 510(k) pre-market notification process with regulatory assistance from Donawa Lifescience. Tournicare announced its success in a LinkedIn post in mid-June. Tournicare CEO Niels van Sparrentak explains:…

June 20, 2026
Maria Donawa publishes LinkedIn article on Proposed MDR Amendments and Clinical Data Requirements

Donawa Lifescience President, Maria E. Donawa, M.D., has authored a ‘Regulatory Recap’ article on LinkedIn titled ‘Proposed MDR Amendments and Clinical Data Requirements.’ Following Dr. Donawa’s February 2025 LinkedIn article on the current MDR’s clinical data requirements, the Commission’s December 2025 proposed MDR amendments have now been reviewed with particular attention to clinical data and…

January 5, 2026
PainChek® secures FDA De Novo Clearance with clinical management from Donawa Lifescience

      Donawa Lifescience congratulates PainChek Ltd on receiving United States (US) Food and Drug Administration (FDA) De Novo clearance for its PainChek® Adult Intelligent Pain Assessment App (DEN240073). This groundbreaking app is the world’s first smart device-based medical device for pain assessment, designed for individuals who are unable to reliably verbalize their pain….

November 12, 2025
Donawa Lifescience delivers first on-line EU Regulatory Seminar in China

Donawa Lifescience provided a two-hour seminar to Chinese delegates on 28 October 2025 in conjunction with Leadvisor Global, a leading professional services platform. Donawa Lifescience had the privilege of delivering the first educational course under the Leadvisor banner: Course One – From China to the EU: Medical Device Regulations and Compliance Strategy, as part of…

November 10, 2025